Lupin (NSE:LUPIN) Beginning Cash Position: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LUPIN Lupin Ltd NSE:LUPIN
91 GF Score
Price ₹2,188.40
GF Value ₹2,595.11
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Lupin Beginning Cash Position?

Lupin NSE:LUPIN +0.78% 91 Beginning Cash Position is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:LUPIN with a GF Score™ of 91/100 and a GF Value™ of ₹2,595.11 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Lupin's Beginning Cash Position for the quarter that ended in Jun. 2026 was ₹0 Mil.

Lupin's annual Beginning Cash Position declined from Mar. 2024 (₹12,318 Mil) to Mar. 2025 (₹9,838 Mil) but then increased from Mar. 2025 (₹9,838 Mil) to Mar. 2026 (₹15,437 Mil).

Lupin Beginning Cash Position Related Terms

Lupin Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Lupin's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lupin Beginning Cash Position Chart

Lupin Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,262.20 9,913.70 12,318.10 9,837.60 15,436.90

Lupin Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:LUPIN
91GF Score
Lupin Ltd NSE:LUPIN
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lupin Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ₹0 Mil mean?
Lupin (NSE:LUPIN) has a Beginning Cash Position of ₹0 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lupin and its competitors.
Is Lupin's Beginning Cash Position too high?
Lupin's current Beginning Cash Position is ₹0 Mil. Overall, Lupin has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lupin's Beginning Cash Position compare to ZTS?
Lupin's Beginning Cash Position of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lupin and its competitors. Lupin's current Beginning Cash Position is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lupin stock overvalued right now?
Based on GuruFocus' analysis, Lupin (NSE:LUPIN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,595.11, compared to a current price of ₹2,188.40 — trading 15.7% below its estimated fair value. The current Beginning Cash Position is ₹0 Mil. Lupin's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Lupin (NSE:LUPIN), the current Beginning Cash Position is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lupin (NSE:LUPIN) Overvalued in 2026?

Based on GuruFocus' analysis, Lupin stock appears to be undervalued. The current stock price of ₹2,188.40 is trading 15.7% below its estimated GF Value™ of ₹2,595.11. GuruFocus considers Lupin to be Modestly Undervalued.

Key valuation signals for NSE:LUPIN:

  • Beginning Cash Position: ₹0 Mil
  • GF Value™: ₹2,595.11 vs. price of ₹2,188.40 (15.7% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the NSE:LUPIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lupin Business Description

Other Exchanges 500257:India
Address Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400055
Lupin Ltd is a specialty and generic drug manufacturing company. The company produces, develops, and markets branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) globally. It has a presence in the Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, GastroIntestinal, and other drug therapy segments. The operations of the company are limited to the segments, namely pharmaceuticals which derives key revenue, and others. It also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India, and other countries.
91GF Score

Get the complete analysis for NSE:LUPIN

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,188.40
Price
₹2,595.11
GF Value